NOT KNOWN FACTUAL STATEMENTS ABOUT OZEMPIC IN STOCK

Even though pricing stays a headwind for cholesterol-reducing drug Repatha, sales nonetheless rose 31% during the quarter as desire continued to grow at a immediate speed.S. current market commencing in January 2024, though step by step raising All round supply all over the rest of the calendar year. We be expecting it is going to get a few months